Sharps Technology Inc

sharpstechnology.com

What Do They Do?

Markets syringe products and related drug-delivery systems to hospitals, clinics, and medical supply organizations. Also holds and stakes Solana as part of its digital-asset treasury strategy.

How Do They Make Money?

Customers buy single-use syringe and packaging products, with payment terms following shipment or delivery. The company also earns SOL staking rewards as each staking period ends.

FY2025 revenue

Who Are Their Customers?

Markets remaining syringe inventory to healthcare providers and organizations and foreign governments, while discussing sales with healthcare companies and distributors.

Do Revenues Turn Into Profits?

No. It lost $282.5M in FY2025.

Operating income, FY2025

−132145% of revenue

Net income, FY2025

−138400% of revenue

How Are They Changing?

Since the FY2025 annual report

Latest quarter: Q2 FY2026, the three months to Jun 30, 2026

Net income: ▼ Now a loss; vs $3.6M in Q2 FY2025

Jun 1, 2026 Company changes its name and shifts focus to an AI-powered finance platform The company said the platform would serve emerging markets across Asia, Latin America, and Africa.
May 29, 2026 Arthur Levine appointed Chief Financial Officer

From product development to distribution The older report centered on developing and commercializing safety syringes and planned manufacturing; the latest describes marketing remaining inventory and sourcing future products from third-party manufacturers, after ending research and manufacturing.

Added a Solana treasury The older report focused on syringe products and their commercialization; the latest also describes a treasury centered on SOL, with expected gains from price appreciation and staking rewards.

Who Do They Compete With?

Competes with Retractable Technologies, Becton Dickinson, Medtronic, Terumo Medical, Smiths Medical, and B Braun

Comments